Endo Pharms Inc Company Profile
✉ Email this page to a colleague
▶ Start for $1
Remove trial restrictions
What is the competitive landscape for ENDO PHARMS INC, and what generic alternatives to ENDO PHARMS INC drugs are available?
ENDO PHARMS INC has four approved drugs.
There are thirteen US patents protecting ENDO PHARMS INC drugs.
There are eighty-one patent family members on ENDO PHARMS INC drugs in thirty-nine countries.
Summary for Endo Pharms Inc
International Patents: | 81 |
US Patents: | 13 |
Tradenames: | 4 |
Ingredients: | 4 |
NDAs: | 4 |
Drugs and US Patents for Endo Pharms Inc
Expired US Patents for Endo Pharms Inc
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Endo Pharms Inc | MEGACE ES | megestrol acetate | SUSPENSION;ORAL | 021778-001 | Jul 5, 2005 | 5,145,684 | See Plans and Pricing |
Endo Pharms Inc | MEGACE ES | megestrol acetate | SUSPENSION;ORAL | 021778-001 | Jul 5, 2005 | 6,592,903 | See Plans and Pricing |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Paragraph IV (Patent) Challenges for ENDO PHARMS INC drugs
Drugname | Dosage | Strength | Tradename | Submissiondate |
---|---|---|---|---|
➤ Subscribe | Nasal Spray | 500 mcg/spray | ➤ Subscribe | 2017-04-28 |
➤ Subscribe | Injection | 250 mg/mL | ➤ Subscribe | 2014-06-11 |
International Patents for Endo Pharms Inc Drugs
Country | Patent Number | Estimated Expiration |
---|---|---|
Slovenia | 1457208 | See Plans and Pricing |
European Patent Office | 2263650 | See Plans and Pricing |
World Intellectual Property Organization (WIPO) | 03086354 | See Plans and Pricing |
European Patent Office | 1457208 | See Plans and Pricing |
Montenegro | 00149 | See Plans and Pricing |
Russian Federation | 2354381 | See Plans and Pricing |
Norway | 335179 | See Plans and Pricing |
>Country | >Patent Number | >Estimated Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.